Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197775) titled 'Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)' on Sept. 26.

Study Type: Observational [Patient Registry]

Primary Sponsor: Endogenex, Inc.

Condition: Type 2 Diabetes Mellitus (T2DM) Type2Diabetes Diabetes Mellitus, Type 2 Type 2 Diabetes Diabetes

Recruitment Status: Not recruiting

Date of First Enrollment: October 2025

Target Sample Size: 500

To know more, visit https://clinicaltrials.gov/study/NCT07197775

Published by HT Digital Content Services with permission from Health Daily Digest....